window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 2, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Drug discovery

  • Drug discovery,Oncology,Partnerships & Funding,Research & Development,Startups and innovations,Technology and platforms

    Symeres and Ambagon partner on molecular glue research in colorectal cancer

    Symeres and Ambagon Therapeutics are collaborating to evaluate molecular glues [...]

    March 31, 2026
  • Artificial Intelligence,Drug discovery,Partnerships & Funding

    Insilico Medicine signs $2.75bn AI drug discovery deal with Eli Lilly

    Insilico Medicine has signed a drug discovery collaboration with Eli [...]

    March 31, 2026
  • Biotech,Drug discovery,Research & Development,Technology and platforms

    Nuclera launches GPCR nanodisc panel to address membrane protein bottleneck in drug discovery

    Nuclera has launched a nanodisc panel designed to improve the [...]

    March 30, 2026
  • Clinical Development,Drug discovery,Oncology,Research & Development

    FoRx Therapeutics presents preclinical data on PARG inhibitor FORX-428 at ACS Spring 2026

    FoRx Therapeutics presents preclinical data on FORX-428, a PARG inhibitor [...]

    March 27, 2026
  • Drug discovery,Gastroenterology,Immunology,Partnerships & Funding,Research & Development

    Quotient and Merck partner on somatic genomics drug targets in inflammatory bowel disease

    Quotient Therapeutics and Merck sign a multi-year collaboration to identify [...]

    March 25, 2026
  • Artificial Intelligence,Drug discovery,Neurosciences,Partnerships & Funding

    insitro and Bristol Myers Squibb expand ALS targets in AI collaboration

    insitro and Bristol Myers Squibb have expanded their ALS collaboration [...]

    March 23, 2026
  • Biotech,Drug Development,Drug discovery,Oncology

    Promatix shows 50-fold potency in colorectal cancer with PBS293 ADC

    Promatix Biosciences has reported preclinical data showing its cis-bispecific ADC [...]

    February 25, 2026
  • Biologics & Biosimilars,Biotech,Drug discovery,European biotech,Healthcare leadership,Movers & Shakers,Opthalmology,Research & Development

    Link Biologics appoints Niall Martin to board as TSG-6 pipeline advances towards clinic

    Link Biologics has appointed Niall Martin to its board as [...]

    February 25, 2026
  • Artificial Intelligence,Drug discovery,Precision medicine,Research & Development

    Promise Bio launches grant to support translational epiproteomics in biotech research

    Promise Bio has launched the Frontier Epiproteomic Innovation Grant, providing [...]

    February 24, 2026
  • Cell & Gene Therapy,Drug discovery,Technology and platforms

    MaxCyte launches 96-well electroporation platform for cell therapy discovery

    MaxCyte, Inc. has launched ExPERT DTx, a 96-well electroporation platform [...]

    February 24, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Nuclera launches GPCR nanodisc panel to address membrane protein bottleneck in drug discovery
    Categories: Biotech, Drug discovery, Research & Development, Technology and platforms
  • Ribbon CEO calls for faster adoption of AI and DNA synthesis to accelerate drug development
    Categories: Biotech, Digital Health, Research & Development
  • FDA signals continued access for desiccated thyroid extract products as manufacturers move toward biologics pathway
    Categories: Regulatory Affairs, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top